MRSAid™ To Be Implemented at Vancouver General Hospital as Part of Infection Control Project

MRSAid product images by Ondine BiomedicalEvery year on April 7th, we celebrate World Health Day to mark the founding of the World Health Organization (WHO). Under this year’s theme of “Combating Drug Resistance,” the WHO is challenging healthcare professionals around the world to take action and implement change to address the growing problem of antibiotic resistance. Ondine is pleased to be able to respond to this challenge by entering into an innovative partnership with one of Canada’s largest hospital to introduce a novel non-antibiotic decolonization therapy aimed at reducing hospital-acquired infections (HAI’s).

Today, we are pleased to announce that Vancouver General Hospital will be implementing the MRSAid™ Photodisinfection System as part of a year-long infection control Quality Improvement Project. This project is being implemented with the objective of reducing the incidence of surgical site infections (SSIs) after major surgical procedures. Every year in Canada, surgical site infections affect approximately 50,000 patients, costing the healthcare system over $200 million. Surgical site infections after major surgeries like cardiac or orthopedic procedures can add well over $100,000 to the cost of care for a single patient. In many cases, the presence of highly antibiotic resistant pathogens such as MRSA further add to patient recovery times and mortality.

It is well known that the presence of pathogenic bacteria such as Staphylococcus aureus in the nose significantly increases the risk of surgical site and other hospital acquired infections. MRSAid™ is designed to be used as part of a comprehensive infection control program to eliminate bacteria in the noses of patients during high infection risk times in the hospital. The project at VGH will focus specifically on decolonizing patients undergoing cardiac, spinal, neurological, breast reconstruction, thoracic, and orthopedic surgeries. Patients in these groups will undergo MRSAid™ treatment for decolonization of the nasal passages and chlorhexidine body wipes to remove pathogenic bacteria from other body sites. Ondine is very excited to be working with infection control specialists at Vancouver General Hospital on this new and, innovative infection control project. To learn more about the MRSAid™ Photodisinfection System, please visit

Related Posts Plugin for WordPress, Blogger...

One Response to “MRSAid™ To Be Implemented at Vancouver General Hospital as Part of Infection Control Project”

  1. Nicole Gould says:

    this is exciting news!! Congratulations Ondine!!!

Leave a Reply

Staypressed theme by Themocracy